These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16548519)

  • 1. Comparison of the human and worm p53 structures suggests a way for enhancing stability.
    Pan Y; Ma B; Levine AJ; Nussinov R
    Biochemistry; 2006 Mar; 45(12):3925-33. PubMed ID: 16548519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In the quest for stable rescuing mutants of p53: computational mutagenesis of flexible loop L1.
    Pan Y; Ma B; Venkataraghavan RB; Levine AJ; Nussinov R
    Biochemistry; 2005 Feb; 44(5):1423-32. PubMed ID: 15683227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds.
    Ho WC; Luo C; Zhao K; Chai X; Fitzgerald MX; Marmorstein R
    Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1484-93. PubMed ID: 17139084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.
    Calhoun S; Daggett V
    Biochemistry; 2011 Jun; 50(23):5345-53. PubMed ID: 21561095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural differences in the DNA binding domains of human p53 and its C. elegans ortholog Cep-1.
    Huyen Y; Jeffrey PD; Derry WB; Rothman JH; Pavletich NP; Stavridi ES; Halazonetis TD
    Structure; 2004 Jul; 12(7):1237-43. PubMed ID: 15242600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R248Q mutation--Beyond p53-DNA binding.
    Ng JW; Lama D; Lukman S; Lane DP; Verma CS; Sim AY
    Proteins; 2015 Dec; 83(12):2240-50. PubMed ID: 26442703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue.
    Wallentine BD; Wang Y; Tretyachenko-Ladokhina V; Tan M; Senear DF; Luecke H
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2146-56. PubMed ID: 24100332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Y220C mutation on p53 and its rescue mechanism: a computer chemistry approach.
    Rauf SM; Endou A; Takaba H; Miyamoto A
    Protein J; 2013 Jan; 32(1):68-74. PubMed ID: 23315175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.
    Merabet A; Houlleberghs H; Maclagan K; Akanho E; Bui TT; Pagano B; Drake AF; Fraternali F; Nikolova PV
    Biochem J; 2010 Mar; 427(2):225-36. PubMed ID: 20113312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot-spot mutants of p53 core domain evince characteristic local structural changes.
    Wong KB; DeDecker BS; Freund SM; Proctor MR; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8438-42. PubMed ID: 10411893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural evolution of C-terminal domains in the p53 family.
    Ou HD; Löhr F; Vogel V; Mäntele W; Dötsch V
    EMBO J; 2007 Jul; 26(14):3463-73. PubMed ID: 17581633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into p53 function from structural studies.
    Arrowsmith CH; Morin P
    Oncogene; 1996 Apr; 12(7):1379-85. PubMed ID: 8622853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
    Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
    Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro structure-function analysis of the beta-strand 326-333 of human p53.
    Chène P; Mittl P; Grütter M
    J Mol Biol; 1997 Nov; 273(4):873-81. PubMed ID: 9367778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library.
    Kawaguchi T; Kato S; Otsuka K; Watanabe G; Kumabe T; Tominaga T; Yoshimoto T; Ishioka C
    Oncogene; 2005 Oct; 24(46):6976-81. PubMed ID: 16007150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of the core domain of p53: insights from computer simulations.
    Madhumalar A; Smith DJ; Verma C
    BMC Bioinformatics; 2008; 9 Suppl 1(Suppl 1):S17. PubMed ID: 18315848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of the DNA-binding-induced loop L1 conformational switch in an engineered human p53 protein.
    Emamzadah S; Tropia L; Vincenti I; Falquet B; Halazonetis TD
    J Mol Biol; 2014 Feb; 426(4):936-44. PubMed ID: 24374182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study.
    Kamaraj B; Bogaerts A
    PLoS One; 2015; 10(8):e0134638. PubMed ID: 26244575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific DNA binding by different classes of human p53 mutants.
    Rolley N; Butcher S; Milner J
    Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.